STOPP/START Version 3 Screen
STOPP/START version 3 screen for a person 65 or older.
Open the calculator → Runs in your browser. Data leaves only if you deliberately send a problem report from the interactive tool.
Example
- Age, years
- 80
- eGFR, mL/min/1.73 m²
- 40
- Benzodiazepine
- Yes
- NSAID
- Yes
- Recurrent falls
- Yes
- Hypertension
- Yes
Result: 3 STOPP criteria and 6 START criteria to review.
The tool opens with these values already filled in. Replace them with your own.
What you enter
- Age, years (65 or older)
- eGFR, mL/min/1.73 m² (optional, for the kidney criteria)
- Digoxin
- Verapamil or diltiazem
- Amlodipine or another dihydropyridine
- Beta-blocker
- Amiodarone
- Loop diuretic (furosemide, bumetanide)
The other 163 fields
- Thiazide diuretic
- Clonidine, methyldopa or moxonidine
- ACE inhibitor
- Angiotensin receptor blocker
- Sacubitril/valsartan
- Spironolactone or eplerenone
- Amiloride or triamterene
- Alpha-1 blocker (doxazosin, tamsulosin)
- Other vasodilator (hydralazine, minoxidil)
- Nitrate
- Sildenafil, tadalafil or vardenafil
- Another drug that prolongs QTc
- Statin
- SGLT2 inhibitor
- Intravenous iron
- Aspirin
- Clopidogrel, prasugrel or ticagrelor
- Ticlopidine
- Warfarin or another vitamin K antagonist
- Dabigatran
- Apixaban, edoxaban or rivaroxaban
- Other P-gp inhibitor (macrolide, azole)
- SSRI
- SNRI (venlafaxine, duloxetine)
- Tricyclic antidepressant
- Other antidepressant (mirtazapine, trazodone)
- Antipsychotic
- Phenothiazine (chlorpromazine, prochlorperazine)
- Benzodiazepine
- Zolpidem, zopiclone or zaleplon
- First-generation antihistamine
- Benztropine, trihexyphenidyl or procyclidine
- Donepezil, rivastigmine or galantamine
- Memantine
- Ginkgo, piracetam or another nootropic
- Levodopa or a dopamine agonist
- Antiepileptic
- Gabapentin or pregabalin
- Two or more anticholinergic drugs
- Metoclopramide
- Proton pump inhibitor
- Oral iron
- Laxative
- Fiber supplement
- Probiotic
- H. pylori eradication therapy
- Megestrol acetate
- Theophylline
- Long-acting muscarinic antagonist inhaler
- Long-acting beta-2 agonist inhaler
- Inhaled corticosteroid
- Home oxygen
- NSAID (by mouth or injection)
- Systemic corticosteroid
- Colchicine
- Allopurinol or febuxostat
- Bisphosphonate
- Denosumab, teriparatide or abaloparatide
- Vitamin D
- Calcium supplement
- DMARD (methotrexate, sulfasalazine)
- Methotrexate
- Folic acid
- Opioid
- Acetaminophen
- Lidocaine patch
- Oxybutynin, tolterodine or another bladder antimuscarinic
- Mirabegron
- Finasteride or dutasteride
- Vaginal estrogen
- Antibiotic
- Nitrofurantoin
- Metformin
- Glyburide, glimepiride or chlorpropamide
- Pioglitazone or rosiglitazone
- Systemic estrogen
- Progestogen
- Testosterone or another androgen
- Levothyroxine
- Desmopressin or vasopressin
- Calcitriol or alfacalcidol
- Phosphate binder
- Erythropoietin or another ESA
- Influenza vaccine this season
- Pneumococcal vaccine
- Zoster vaccine
- COVID-19 vaccine
- Heart failure, reduced ejection fraction
- Heart failure, preserved ejection fraction
- NYHA class III or IV heart failure
- Hypertension
- Severe or labile hypertension
- Coronary artery disease
- Cerebrovascular or peripheral arterial disease
- Ischemic stroke or TIA
- Atrial fibrillation
- Supraventricular tachyarrhythmia
- Bradycardia, heart block or unexplained syncope
- Known QTc prolongation
- Severe symptomatic aortic stenosis
- Orthostatic hypotension or syncope
- Symptomatic hypotension
- Dependent ankle edema
- Iron deficiency
- Age 85+ with frailty, life expectancy under 3 years
- Bleeding risk, recent bleeding or major hemorrhage
- History of venous thromboembolism
- First DVT, no continuing provoking factor
- First pulmonary embolism, no continuing provoking factor
- Dementia or chronic cognitive impairment
- Behavioral and psychological symptoms of dementia
- Delirium
- Major depression
- Persistent severe anxiety
- Psychosis
- Insomnia
- Parkinsonism or dementia with Lewy bodies
- Parkinson disease with disability
- Drug-induced parkinsonism or EPS
- Seizure disorder
- Essential tremor
- Restless legs syndrome
- Recurrent falls
- Narrow-angle glaucoma
- Peptic ulcer disease or GI bleeding
- Esophagitis, gastritis or severe reflux
- Gastric antral vascular ectasia (GAVE)
- H. pylori peptic ulcer
- Dysphagia
- Chronic constipation
- Diverticulosis
- COPD
- Asthma
- Chronic hypoxemia or respiratory failure
- Osteoarthritis
- Rheumatoid arthritis
- Gout
- Osteoporosis or fragility fracture
- Vitamin D deficiency (housebound, falls or osteopenia)
- Denosumab stopped
- Teriparatide or abaloparatide stopped
- Moderate to severe pain, not arthritis
- Localized neuropathic pain
- BMI under 18 or chronic liver disease
- BPH, LUTS or urinary retention
- Urinary incontinence or frequency
- Asymptomatic bacteriuria
- Recurrent urinary tract infections (women)
- Symptomatic atrophic vaginitis
- Erectile dysfunction causing distress
- Kidney disease with proteinuria
- Low calcium with secondary hyperparathyroidism
- Phosphate persistently above 5.5 mg/dL
- Symptomatic anemia of kidney disease
- Type 2 diabetes
- Frequent hypoglycemia
- History of breast cancer
- Intact uterus
- Subclinical hypothyroidism (TSH under 10)
- Potassium under 3.0 mmol/L
- Potassium above 5.5 mmol/L
- Sodium under 130 mmol/L
- Corrected calcium above 2.65 mmol/L
How this is calculated
Citation
O'Mahony D, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med 2023;14:625-632, Appendix 1: 133 STOPP and 57 START criteria (CC BY 4.0). Read the source ↗
A reference and educational tool. Not medical, legal, or financial advice, and not a substitute for clinician judgment.